FILTER CONTENT

Filters
Filters
Risk Levels
Investment Styles
Industries
Show (162)
Cancel

Research

  • 7investing logo next to the Coherus BioSciences logo.
    By Published On: March 21, 2025

    Sell Coherus BioSciences

  • 7investing logo next to the Avita Medical logo.
    By Published On: February 17, 2025

    AVITA Medical: 2025 Will Be an “Inflection Point Year”

    AVITA Medical is continuing to show signs of progress. Its recently-reported fourth quarter [...]

  • By Published On: September 4, 2024

    United Therapeutics is Leading a Biotech Revolution. Here’s Why it Needs to Be on Your Watchlist.

    United Therapeutics (Nasdaq: UTHR) is a very smart and innovative company. In addition [...]

  • By Published On: July 1, 2024

    Cassava Sciences: Is The Fraud Investigation Just Smoke…or an Actual Fire?

    Cassava Sciences (Nasdaq: SAVA), the independently-owned biotech company who's developing a cutting-edge cure [...]

  • 7investing logo next to the BeiGene logo.
    By Published On: May 8, 2024

    BeiGene Deep Dive: May 2024

  • By Published On: May 1, 2024

    May 2024 Stock Rec #1

  • Fluorescent green chemical structure.
    By Published On: April 2, 2024

    Contest Matchup #6: CRISPR Therapeutics vs Seres Therapeutics

    The battle of the biotech blockbusters. Which innovative drug developer is the better [...]

  • By Published On: February 27, 2024

    3 Takeaways from the 2024 WSJ Health Forum

    I recently attended the Wall Street Journal’s 2024 Health Forum in Boston. It showcased [...]

  • An artistic image of a doctor using technology to work with a patient's genome.
    By Published On: February 26, 2024

    Krystal Biotech is Soaring. But the Good Times Are Just Getting Started.

    Krystal Biotech's (Nasdaq: KRYS) stock is up 36% today, after a fantastic morning [...]

  • An image of a scientist holding test tube and analyzing data DNA
    By Published On: February 6, 2024

    AI is Bringing Synthetic Biology Back to Life

    “Synthetic biology and artificial intelligence will emerge as the two most dominant technologies [...]

  • By Published On: January 17, 2024

    Why Seres Therapeutics is My Best Buy in January

    Just last week, I named Seres Therapeutics (Nasdaq: MCRB) as my Best Buy for January. [...]

  • By Published On: November 3, 2023

    Is Seres Therapeutics Preparing To Be Acquired?

    Seres Therapeutics (Nasdaq: MCRB) is preparing to be acquired. Or at least that's [...]

  • By Published On: October 1, 2023

    October 2023 Stock Rec #6

  • By Published On: October 1, 2023

    Seres Therapeutics Deep Dive: October 2023

  • By Published On: September 1, 2023

    September 2023 Stock Rec #2

  • By Published On: September 1, 2023

    Cassava Sciences Deep Dive: September 2023